Genes, Drugs and Stem Cells - Novel Therapies
The Master of Science in Genes, Drugs and Stem Cells - Novel Therapies at Imperial College London is a one-year, full-time program that explores the latest advances in genetics, drug discovery, and stem cell research for the development of novel therapies. Students will study gene therapies, stem cell biology, regenerative medicine, and drug development, with an emphasis on translating scientific discoveries into clinical treatments.
Graduates will be well-equipped for careers in biotechnology, pharmaceutical research, and clinical research, where they can contribute to the development of next-generation therapies that address genetic disorders and regenerative medicine. The program’s emphasis on innovative therapies ensures that students are positioned at the forefront of medical research and treatment development.
Key information
Key Facts
Program Title: Master of Science in Genes, Drugs and Stem Cells - Novel Therapies
Degree Type: Master of Science (MSc)
Duration: 1 year
Mode of Study: Full-time, On Campus
Application Deadline: 30th June 2026
Location: Imperial College London, United Kingdom
Field of Study: Bio & Biomedical Engineering
Language of Instruction: English
Program Structure
Semester 1 – Core Genetic and Stem Cell Research
- Molecular Genetics and Genomics
- Principles of Stem Cell Biology
- Pharmacogenomics and Drug Discovery
- Research Methods in Biomedical Science
Semester 2 – Advanced Applications and Research Project
- Novel Therapeutic Approaches
- Stem Cell Therapy and Regenerative Medicine
- Independent Research Project
- Elective Modules in Gene Therapy, Personalized Medicine, or Translational Research
Career Opportunities
Graduates from this program are prepared for careers in biomedical research, pharmaceuticals, and regenerative medicine. They can work in research institutions, biotech companies, pharmaceutical development, and clinical research centers, contributing to the design, testing, and implementation of novel therapies. The program equips students with experimental, analytical, and translational research skills, enabling them to investigate gene functions, develop innovative drug therapies, and advance stem cell technologies. Graduates can also pursue roles in drug development, gene therapy research, clinical translation, or biomedical consultancy, and they are well-prepared for doctoral studies in genetics, pharmacology, or stem cell science.
Why Choose This Program
This program provides a one-year intensive pathway into genes, drugs, and stem cell research, focusing on cutting-edge therapeutic approaches. It emphasizes molecular genetics, pharmacogenomics, and regenerative medicine, allowing students to gain hands-on experience in designing and implementing innovative therapies. The independent research project provides practical training in experimental design, data analysis, and translational research, helping students build a professional portfolio. Graduates leave the program with the skills and knowledge to make an immediate impact in biomedical research, pharmaceutical development, and regenerative medicine, or to pursue advanced doctoral studies in genetics and stem cell therapy.
Contact Information
For further information, please contact the admissions office at:
Phone: +44 (0)20 7589 5111
Email: admissions@imperial.ac.uk
Address: Imperial College London, South Kensington Campus, London SW7 2AZ, United Kingdom
